A detailed history of Geode Capital Management, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Geode Capital Management, LLC holds 46,671 shares of PRQR stock, worth $153,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,671
Previous 46,671 -0.0%
Holding current value
$153,080
Previous $77,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.15 - $2.21 $11,934 - $22,935
10,378 Added 28.6%
46,671 $92,000
Q3 2021

Nov 12, 2021

BUY
$5.16 - $8.47 $56,182 - $92,221
10,888 Added 42.86%
36,293 $303,000
Q2 2021

Aug 13, 2021

BUY
$5.75 - $7.59 $33,769 - $44,576
5,873 Added 30.07%
25,405 $171,000
Q1 2021

May 12, 2021

BUY
$4.14 - $9.22 $25,452 - $56,684
6,148 Added 45.94%
19,532 $129,000
Q4 2020

Feb 12, 2021

SELL
$3.58 - $4.85 $161,676 - $219,030
-45,161 Reduced 77.14%
13,384 $56,000
Q3 2020

Nov 13, 2020

BUY
$4.79 - $6.3 $14,963 - $19,681
3,124 Added 5.64%
58,545 $280,000
Q2 2020

Aug 13, 2020

BUY
$4.5 - $6.53 $6,795 - $9,860
1,510 Added 2.8%
55,421 $336,000
Q1 2020

May 14, 2020

BUY
$5.25 - $9.9 $4,410 - $8,316
840 Added 1.58%
53,911 $295,000
Q4 2019

Feb 13, 2020

BUY
$5.84 - $10.51 $137,590 - $247,615
23,560 Added 79.83%
53,071 $525,000
Q1 2019

May 14, 2019

BUY
$12.5 - $18.48 $128,975 - $190,676
10,318 Added 53.76%
29,511 $409,000
Q4 2018

Feb 13, 2019

BUY
$15.25 - $22.4 $36,218 - $53,200
2,375 Added 14.12%
19,193 $302,000
Q3 2018

Nov 13, 2018

BUY
$6.45 - $21.6 $36,571 - $122,472
5,670 Added 50.86%
16,818 $325,000
Q2 2018

Aug 14, 2018

BUY
$2.95 - $7.45 $32,886 - $83,052
11,148 New
11,148 $81,000
Q4 2017

Feb 13, 2018

SELL
$2.8 - $4.8 $34,190 - $58,612
-12,211 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$4.35 - $6.45 $3,419 - $5,069
-786 Reduced 6.05%
12,211 $59,000
Q2 2017

Aug 14, 2017

BUY
N/A
12,997
12,997 $67,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $234M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.